Skip to content
GILDGilead Sciences Inc.

GILD Earnings

Gilead Sciences Inc. next reports earnings on October 29, 2026. Track record: 4/4 beats.

Earnings Reported

October 29, 2026

Current Price

$170.68

EPS Estimate

Earnings Per Share

$2.03

+9.2% YoY

Trailing EPS

Last 12 months earnings

-$2.65

Beat Rate

4/4

100%

Forward P/E

Price-to-Earnings ratio

17.2

Margin: -10.6%

Analyst Rating

Buy

26 analysts

Analyst Sentiment

Buy26 analysts
Target: $160.19-6.1%Full analysis →

Trading above average target while rated "Buy." Price may have rallied faster than analysts updated targets.

Earnings History

4/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-09-30$2.19$2.55+16.2%Beat
2026-06-30-$7.25-$6.75+6.9%Beat
2026-03-31$1.91$2.03+6.2%Beat
2025-12-31$1.81$1.86+2.8%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$2.03+9.2%
Next Qtr(+1q)$2.18+7.3%
Current Year(0y)-$0.45-105.5%
Next Year(+1y)$9.91+2301.7%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$2.03

Revenue Estimate

$8.2B

Annual EPS Est.

-$0.45

-105.5% YoY

GILD Earnings FAQ

When is GILD's next earnings date?

Gilead Sciences Inc. (GILD) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $2.03.

Does GILD usually beat earnings estimates?

Gilead Sciences Inc. has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).

What is GILD's trailing EPS?

Gilead Sciences Inc.'s trailing twelve-month EPS is -$2.65. This is calculated from the last four quarters of reported earnings.

What do analysts think about GILD?

26 Wall Street analysts cover Gilead Sciences Inc.. The consensus rating is "Buy" with an average price target of $160.19, implying 6.1% downside from the current price.